New tech promises to change the way drug candidates are selected at the preclinical level to enter into clinical trials—and to maximize their chances of success
The next-generation 4D-Nucleofector® Platform is the leading non-viral cell transfection method for a wide variety of cell types—even those traditionally hard to transfect
Simplified design reduces manufacturing time and offers improved functionality to help streamline antibody discovery, cell line development, cell therapy, and synthetic biology workflows